Gender Discrimination Suits: Cases Against Pharma Continue Even As Payouts Slow
This article was originally published in The Pink Sheet Daily
Novartis will pay $8m to settle second case; last year Daiichi Sankyo settled gender discrimination class action for the same amount and action against Bayer was dismissed following confidential resolution. Cases are ongoing against Merck and Forest.
Register for our free email digests: